Even after a booster, the CKD patients had a decreased proportion of polyfunctional CD8+ T cells (CD8+IFN-γ+IL-2+TNF-α+) compared to the controls, suggesting persistently deficient immune responses in this group (Figure 3D). The gene discussed is IL2; the disease is chronic kidney disease.